Coherence Neuro
San Francisco, United States
◆ About Coherence Neuro
San Francisco startup developing AI models and brain implants that decode electrical signals tied to brain tumors for glioblastoma treatment.
◆ What sets it apart
Its SOMA-1 implant combines continuous sensing of tumor-associated electrical activity with targeted electrical stimulation in a closed-loop bioelectronic therapy.
◆ Sectors
◆ Business
Modelhardware
CustomerNeurosurgeons, neuro-oncology researchers, hospitals, and eventually patients with glioblastoma and other brain tumors
◆ Notable
- Temporarily implanted its investigational device in three patients undergoing brain-tumor surgery at Royal Melbourne Hospital
- Developed SOMA-1 for real-time monitoring and stimulation of glioblastoma-associated electrical activity
- Raised a reported $45 million seed round led by the OpenAI Startup Fund and Founders Fund
◆ Backing funds on Raise
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Coherence Neuro do?
San Francisco startup developing AI models and brain implants that decode electrical signals tied to brain tumors for glioblastoma treatment.
Where is Coherence Neuro based?
Coherence Neuro is based in San Francisco, United States, founded in 2022.
How much has Coherence Neuro raised?
Coherence Neuro has raised $45M in tracked funding and is currently at the seed stage.
Who has invested in Coherence Neuro?
Investors in Coherence Neuro include OpenAI Startup Fund, Founders Fund, Artesian, Topology Ventures, Blackbird Ventures, Possible Ventures, XEIA and Jumpspace.